Influence of Grading on Management and Outcome in Mucoepidermoid Carcinoma of the Parotid—A Multi‐institutional Analysis

To evaluate clinical outcome of low (G1), intermediate (G2), and high‐(G3) grade mucoepidermoid carcinomas (MEC) of the parotid gland.

[1]  J. Shah,et al.  NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022. , 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

[2]  Z. Guss,et al.  Overall and cause-specific survival for mucoepidermoid carcinoma of the major salivary glands: Analysis of 2210 patients , 2020, World journal of clinical oncology.

[3]  G. Calais,et al.  Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  R. Gilbert,et al.  Nodal Metastases in Acinic Cell Carcinoma of the Parotid Gland , 2019, Journal of clinical medicine.

[5]  R. Weber,et al.  NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[6]  J. Roh,et al.  Survival Outcome of Intermediate-Grade Salivary Gland Carcinoma , 2017, Oncology.

[7]  T. Day,et al.  Predictors of Nodal Metastasis in Parotid Malignancies , 2016, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[8]  Charles S. Coffey,et al.  What is the role of elective neck dissection in low‐, intermediate‐, and high‐grade mucoepidermoid carcinoma? , 2016, The Laryngoscope.

[9]  R. Gilbert,et al.  Outcome analysis of 215 patients with parotid gland tumors: a retrospective cohort analysis , 2015, Journal of Otolaryngology - Head & Neck Surgery.

[10]  M. Ruan,et al.  Prognostic factors in primary salivary gland mucoepidermoid carcinoma: an analysis of 376 cases in an Eastern Chinese population. , 2014, International journal of oral and maxillofacial surgery.

[11]  J. Shah,et al.  Treatment of the Neck in Carcinoma of the Parotid Gland , 2014, Annals of Surgical Oncology.

[12]  S. Roman,et al.  Histologic grade as prognostic indicator for mucoepidermoid carcinoma: A population‐level analysis of 2400 patients , 2014, Head & neck.

[13]  D. Farwell,et al.  Mucoepidermoid carcinoma of the parotid gland treated by surgery and postoperative radiation therapy: Clinicopathologic correlates of outcome , 2013, The Laryngoscope.

[14]  A. Garden,et al.  Prognostic factors in mucoepidermoid carcinoma of the salivary glands , 2012, Cancer.

[15]  L. Harrison,et al.  Postoperative radiation therapy for small, low‐/intermediate‐grade parotid tumors with close and/or positive surgical margins , 2012, Head & neck.

[16]  P. Bradley,et al.  Diagnosis and management of parotid carcinoma with a special focus on recent advances in molecular biology , 2012, Head & neck.

[17]  P. Pai,et al.  Mucoepidermoid carcinoma of the parotid gland: Factors affecting outcome , 2011, Head & neck.

[18]  T. Ettl,et al.  Salivary gland mucoepidermoid carcinoma is a clinically, morphologically and genetically heterogeneous entity: a clinicopathological study of 40 cases with emphasis on grading, histological variants and presence of the t(11;19) translocation , 2011, Histopathology.

[19]  R. Seethala.  An Update on Grading of Salivary Gland Carcinomas , 2009, Head and neck pathology.

[20]  Simion I. Chiosea,et al.  Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma , 2008, Cancer.

[21]  J. Califano,et al.  Consensus statement on the classification and terminology of neck dissection. , 2008, Archives of otolaryngology--head & neck surgery.

[22]  A. Mäkitie,et al.  Management and Outcome of Patients With Mucoepidermoid Carcinoma of Major Salivary Gland Origin: A Single Institution's 30‐Year Experience , 2008, The Laryngoscope.

[23]  V. Pankratz,et al.  Mucoepidermoid carcinoma of the parotid gland: the Mayo clinic experience. , 2004, Archives of otolaryngology--head & neck surgery.

[24]  P. Levine,et al.  Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. , 2002, Archives of otolaryngology--head & neck surgery.

[25]  Philip Cole,et al.  Incidence Rates of Salivary Gland Tumors: Results from a Population-Based Study , 1999, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[26]  G. Ellis,et al.  Mucoepidermoid carcinoma of intraoral salivary glands evaluation and application of grading criteria in 143 cases , 1992, Cancer.

[27]  R. Spiro,et al.  The indications for elective treatment of the neck in cancer of the major salivary glands , 1992, Cancer.

[28]  G. Seifert.  Histological Typing of Salivary Gland Tumours , 1991, World Health Organization.

[29]  C. Hamberger,et al.  Principles of treatment of different types of parotid tumors. , 1974, The Laryngoscope.

[30]  M. Stadler,et al.  Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation. , 2019, American journal of otolaryngology.

[31]  K. Ang,et al.  Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[32]  M. Fried,et al.  Determinants of survival in parotid gland carcinoma: a population-based study. , 2005, American journal of otolaryngology.

[33]  W. Payne.  Histological Typing of Salivary Gland Tumours , 1973 .